BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND MEN1, ENSG00000133895, 4221
113 results:

  • 1. gastric neuroendocrine neoplasms.
    Lamberti G; Panzuto F; Pavel M; O'Toole D; Ambrosini V; Falconi M; Garcia-Carbonero R; Riechelmann RP; Rindi G; Campana D
    Nat Rev Dis Primers; 2024 Apr; 10(1):25. PubMed ID: 38605021
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Spatial profiling reveals tissue-specific neuro-immune interactions in gastroenteropancreatic neuroendocrine tumors.
    Duan S; Sawyer TW; Witten BL; Song H; Else T; Merchant JL
    J Pathol; 2024 Mar; 262(3):362-376. PubMed ID: 38229586
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Management of gastric Neuroendocrine Tumors: A Review.
    Sok C; Ajay PS; Tsagkalidis V; Kooby DA; Shah MM
    Ann Surg Oncol; 2024 Mar; 31(3):1509-1518. PubMed ID: 38062290
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Comparison of perioperative and histopathologic outcomes among neoadjuvant treatment strategies for locoregional gastric cancer.
    Janczewski LM; Logan CD; Vitello DJ; Buchheit JT; Abad JD; Bentrem DJ; Chawla A
    J Surg Oncol; 2024 Mar; 129(3):481-488. PubMed ID: 37986548
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Current understanding of pathogenetic mechanisms in neuroendocrine neoplasms.
    Modica R; Liccardi A; Minotta R; Cannavale G; Benevento E; Colao A
    Expert Rev Endocrinol Metab; 2024; 19(1):49-61. PubMed ID: 37936421
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Recurrent gastric amphicrine tumor with neuroendocrine and pancreatic acinar cell differentiation and somatic men1 inactivation arisen during immunotherapy.
    Mastrosimini MG; Mafficini A; Tondulli L; Milella M; Piccoli P; Mattiolo P; Fassan M; Hong SM; Scarpa A; Luchini C
    Virchows Arch; 2023 Sep; 483(3):415-419. PubMed ID: 37581694
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinically Defined Mutations in
    Duan S; Sheriff S; Elvis-Offiah UB; Witten BL; Sawyer TW; Sundaresan S; Cierpicki T; Grembecka J; Merchant JL
    Cancer Res Commun; 2023 Jul; 3(7):1318-1334. PubMed ID: 37492626
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Cutaneous lesions and other non-endocrine manifestations of Multiple Endocrine Neoplasia type 1 syndrome.
    Pierotti L; Pardi E; Dinoi E; Piaggi P; Borsari S; Della Valentina S; Sardella C; Michelucci A; Caligo MA; Bogazzi F; Marcocci C; Cetani F
    Front Endocrinol (Lausanne); 2023; 14():1191040. PubMed ID: 37484956
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. MENIN-mediated regulation of gastrin gene expression and its role in gastrinoma development.
    Elvis-Offiah UB; Duan S; Merchant JL
    FASEB J; 2023 May; 37(5):e22913. PubMed ID: 37078545
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Under-Representation of Racial Groups in Genomics Studies of Gastroenteropancreatic Neuroendocrine Neoplasms.
    Herring BR; Bonner A; Guenter RE; Vickers S; Yates C; Lee G; Dhall D; Chen H; Rose JB
    Cancer Res Commun; 2022 Oct; 2(10):1162-1173. PubMed ID: 36969744
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Indications for genetic study in gastro-entero-pancreatic and thoracic neuroendocrine tumors.
    Araujo-Castro M
    Endocrinol Diabetes Nutr (Engl Ed); 2023 Mar; 70 Suppl 1():63-73. PubMed ID: 36396595
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Association of Pathogenic Variants in Hereditary cancer Genes With Multiple Diseases.
    Zeng C; Bastarache LA; Tao R; Venner E; Hebbring S; Andujar JD; Bland ST; Crosslin DR; Pratap S; Cooley A; Pacheco JA; Christensen KD; Perez E; Zawatsky CLB; Witkowski L; Zouk H; Weng C; Leppig KA; Sleiman PMA; Hakonarson H; Williams MS; Luo Y; Jarvik GP; Green RC; Chung WK; Gharavi AG; Lennon NJ; Rehm HL; Gibbs RA; Peterson JF; Roden DM; Wiesner GL; Denny JC
    JAMA Oncol; 2022 Jun; 8(6):835-844. PubMed ID: 35446370
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. gastric neuroendocrine neoplasms: a primer for radiologists.
    Roseland ME; Francis IR; Shampain KL; Stein EB; Wasnik AP; Millet JD
    Abdom Radiol (NY); 2022 Dec; 47(12):3993-4004. PubMed ID: 35411433
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Gastrin: From Physiology to Gastrointestinal Malignancies.
    Duan S; Rico K; Merchant JL
    Function (Oxf); 2022; 3(1):zqab062. PubMed ID: 35330921
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A case report of multiple endocrine neoplasia type 1 and autoimmune disease: Coincidence or correlation?
    Chaves C; Nunes da Silva T; Dias Pereira B; Anselmo J; Claro I; Cavaco BM; Saramago A; Leite V
    Medicine (Baltimore); 2021 Dec; 100(49):e28145. PubMed ID: 34889280
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Comparison of clinical characteristics between sporadic gastrinoma and multiple endocrine neoplasia type 1-related gastrinoma].
    Guo Y; Chen LH; Liu M; Zhang YX; Zhang N; Chen J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):875-882. PubMed ID: 34674462
    [No Abstract]    [Full Text] [Related]  

  • 17. The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms.
    Venizelos A; Elvebakken H; Perren A; Nikolaienko O; Deng W; Lothe IMB; Couvelard A; Hjortland GO; Sundlöv A; Svensson J; Garresori H; Kersten C; Hofsli E; Detlefsen S; Krogh M; Sorbye H; Knappskog S
    Endocr Relat Cancer; 2021 Nov; 29(1):1-14. PubMed ID: 34647903
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis.
    Ito T; Masui T; Komoto I; Doi R; Osamura RY; Sakurai A; Ikeda M; Takano K; Igarashi H; Shimatsu A; Nakamura K; Nakamoto Y; Hijioka S; Morita K; Ishikawa Y; Ohike N; Kasajima A; Kushima R; Kojima M; Sasano H; Hirano S; Mizuno N; Aoki T; Aoki T; Ohtsuka T; Okumura T; Kimura Y; Kudo A; Konishi T; Matsumoto I; Kobayashi N; Fujimori N; Honma Y; Morizane C; Uchino S; Horiuchi K; Yamasaki M; Matsubayashi J; Sato Y; Sekiguchi M; Abe S; Okusaka T; Kida M; Kimura W; Tanaka M; Majima Y; Jensen RT; Hirata K; Imamura M; Uemoto S
    J Gastroenterol; 2021 Nov; 56(11):1033-1044. PubMed ID: 34586495
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Vitamin D deficiency and tumor aggressiveness in gastroenteropancreatic neuroendocrine tumors.
    Altieri B; Barrea L; Modica R; Bottiglieri F; de Cicco F; Muscogiuri G; Circelli L; Savarese G; Di Somma C; Savastano S; Colao A; Faggiano A
    Endocrine; 2022 Feb; 75(2):623-634. PubMed ID: 34533768
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Neuroendocrine neoplasms of the esophagus and stomach.
    Mastracci L; Rindi G; Grillo F; Solcia E; Campora M; Fassan M; Parente P; Vanoli A; La Rosa S
    Pathologica; 2021 Feb; 113(1):5-11. PubMed ID: 33686305
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.